Current Molecular Therapeutic Agents and Drug Candidates for Mycobacterium abscessus
Mycobacterium abscessus has been recognised as a dreadful respiratory pathogen among the non-tuberculous mycobacteria (NTM) because of misdiagnosis, prolonged therapy with poor treatment outcomes and a high cost. This pathogen also shows extremely high antimicrobial resistance against current antibi...
Saved in:
Main Authors: | Nguyen Thanh Quang (Author), Jichan Jang (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2021-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Omadacycline Potentiates Clarithromycin Activity Against Mycobacterium abscessus
by: Bui Thi Bich Hanh, et al.
Published: (2021) -
Cord formation in Mycobacterium abscessus
by: C Adikaram, et al.
Published: (2015) -
Moles of Molecules against <i>Mycobacterium abscessus</i>: A Review of Current Research
by: Mario Cocorullo, et al.
Published: (2023) -
Mycobacteriophage-antibiotic therapy promotes enhanced clearance of drug-resistant Mycobacterium abscessus
by: Matt D. Johansen, et al.
Published: (2021) -
Disseminated Mycobacterium abscessus infection as a cause of autosensitization
by: Margit Lai Wun Juhasz, MD, MSc, et al.
Published: (2021)